This inventor holds 2 USPTO granted patents. Top assignee: Otsuka Pharmaceutical. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Arash Raoufinia and His Pharmaceutical Patents
Introduction
Arash Raoufinia is an inventor based in McLean, Virginia, whose patent work includes methods for initiating aripiprazole treatment. He is associated with Otsuka Pharmaceutical and has 2 patents.
Latest Patents
Raoufinia’s listed patent, “Methods for Dose Initiation of Aripiprazole Treatments,” describes a first-day treatment approach for patients who need aripiprazole. The method involves administering two separate intramuscular depot injections, each containing 100 to 500 mg of aripiprazole, at separate gluteal and/or deltoid injection sites, along with a single oral dose of aripiprazole.
Career Highlights
Raoufinia’s patent activity reflects work on pharmaceutical treatment methods, particularly the initiation of aripiprazole therapy. His listed company affiliation is Otsuka Pharmaceutical.
Collaborations
Matthew Harlin and Xiaofeng Wang are identified as Raoufinia’s coworkers.
Conclusion
Arash Raoufinia’s patent work focuses on a method for initiating aripiprazole treatment, connecting his pharmaceutical innovation activity with his affiliation at Otsuka Pharmaceutical.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile